An Extension Study of Efficacy and Safety of FTY720 in Patients With Relapsing Multiple Sclerosis
This study is enrolling participants by invitation only.
Sponsor:
Novartis
Collaborator:
Mitsubishi Tanabe Pharma Corporation
Information provided by (Responsible Party):
Novartis
ClinicalTrials.gov Identifier:
NCT00670449
First received: April 28, 2008
Last updated: April 13, 2012
Last verified: April 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is enrolling participants by invitation only. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | April 2012 (Final data collection date for primary outcome measure) |